The import and export process for medicines manufactured under cross-border contract manufacturing involves regulation by several departments. Applicants should ensure that all relevant licences are in place, including Hong Kong pharmaceutical licences and import and export licences. For imports, prepare complete declaration documents in advance and ensure that product registration information, test reports, transport documents and other materials meet the requirements. We recommend establishing an efficient supply chain management system and maintaining good communication with logistics providers, Customs and regulatory authorities, so that inspections and requests for additional information can be handled promptly and customs clearance can be completed both compliantly and efficiently.
HONG KONG DRUG LICENSING
How can compliance and efficiency be ensured in the import and export process for medicines manufactured under cross-border contract manufacturing?
A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.
Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.
Back to Category J: Cross-border Medicines and Industry Practice (Q451-Q500) Search more questions